IRBM at ENA 2026

Nov 18–20, 2026 Barcelona, Spain ~1.5k attendees Website

IRBM brings 2 presentations to ENA 2026 in Barcelona. Its posters centre on brain tumors, from markers of drug response to patient organoid models. Transcriptomic profiling picks out glioblastoma responders to brain-penetrant SHP2 inhibition, and C3PO uses complex 3D patient organoids for preclinical drug testing.

OrganizationENA 2026 Attendance
IRBM
Pomezia, Italy
CROs & CDMOs
Contract drug discovery company offering medicinal chemistry, biology and preclinical services.
Poster
Fri Nov 20
10:45–11:15am
1:30–3pm

Explore the full ENA 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Barcelona. Leave your work email and we’ll be in touch.

Privacy

Download the full ENA 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Instantly find 20 buyers from IRBM

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with or endorsed by EORTC, the NCI or the AACR. Submit a correction